DHL launches new service for products handled at extremely low temperatures
DHL Global Forwarding has enhanced its cold chain logistics offerings through the transport of shipments at frozen or cryogenic temperatures.
Designed for customers from the life sciences and healthcare industry with an increasing need for sophisticated cryogenic logistics solutions, this service is maintained by LifeConEx, DHL's temperature management specialist, in collaboration with Cryoport, a provider of complete global frozen shipping services.
David Bang, CEO LifeConEx said: "By introducing this latest solution in collaboration with Cryoport, we are further strengthening our dedication to the life sciences and healthcare industry.
“It is specifically designed for customers who require that cryogenic temperature be reliably maintained during storage and transportation of their materials. It also relieves them from more precarious shipping methods such as dry ice or use of hazardous liquid nitrogen"
For DHL's life science and healthcare customers, the new service combines express delivery speed and Cryoport's best-in-class solution for shipping temperature-sensitive products and biological materials in a deep-frozen state.
The integral part of the new service is a non-hazardous liquid nitrogen dry vapour shipper which has an IATA A152 waiver and is classified as non-hazardous, providing 10 days of holding time at minus 150 º Celsius in a safe and environmentally friendly manner.
Compared to dry ice, which needs to be replenished every few days and is prone to temperature deviations, this technology offers more reliability, which is particularly critical for fragile and temperature-sensitive biomaterials. The solution will include a temperature monitoring tool and customers can track their shipments at any given time via an online platform.
The new service is an addition to DGF's other leading temperature controlled services and complementary to DHL Express' Medical Express by uniting the global Life Sciences & Healthcare network of DHL with Cryoport's advanced solution for deep frozen logistics.
Cryoport Express shippers are validated to maintain a constant cryogenic temperature and mitigate degradation concerns and the loss of high-value, temperature-sensitive materials. Together, both companies offer the optimal solution at lower overall logistics costs for the Life Sciences and Healthcare sector across the globe.
DHL Claim Multi-Sector Collaboration Key to Fighting COVID
Since January, global logistics leader DHL has distributed more than 200 million doses of the COVID vaccine to 120+ countries around the globe. While the US and UK recently rolled out immunisation plans to most citizens, countries with less developed infrastructure still desperately need more doses. In the United Arab Emirates (UAE), which currently has one of the highest per-capita immunisation rates, the government set up storage facilities to cover domestic and international demand. But storage, as we’ve learned, is little help if you can’t transport the goods.
This is where logistics leaders such as DHL make their impact. The company built over 50 new partnerships, bilateral and multilateral, to collaborate with pharmaceutical and private sector firms. With more than 350 DHL centres pressed into service, the group operated 9,000+ flights to ship the vaccine where it needed to go.
With new pandemic knowledge, DHL just released its “Revisiting Pandemic Resilience” white paper, which examined the role of logistics and supply chain companies in handling COVID-19. As Thomas Ellman, Head of Clinical Trials Logistics at DHL, said: “The past one year has highlighted the importance of logistics and supply chain management to manage the pandemic, ensure business continuity and protect public health. It has also shown us that together we are stronger”.
Multisector partnerships, DHL said, enabled rapid, effective vaccine distribution. While international scientists developed a vaccine in record time—five times faster than any other vaccine in history—manufacturers ramped up production and logistics teams rolled out distribution three times faster than expected. When commercial routes faced backups, logistics operators worked with military officers to transport vaccines via helicopters and boats.
In the UAE, the public-private HOPE Consortium distributed billions of COVID-19 doses to its civilians as well as other countries in need by partnering with commercial organisations such as DHL. For the first time, apropo for an unprecedented pandemic, logistics companies made strong connections with public health and government.
“While the race against the virus continues, leveraging the power of such collaborations and data analytics will be key”, said Katja Busch, Chief Commercial Officer DHL and Head of DHL Customer Solutions & Innovation. “We need to remain prepared for high patient and vaccine volumes, maintain logistics infrastructure and capacity, while planning for seasonal fluctuations by providing a stable and well-equipped platform for the years to come”.
How Do We Sustain Immunisation?
By the end of 2021, experts estimate that we need approximately 10 billion doses of vaccines—many of which will be shipped to areas of the world, such as India, South Africa, and Brazil, that lack significant infrastructure. This is perhaps the greatest divide between countries that have rolled out successful immunisation programmes and those that have not. As Busch noted, “the UAE’s significant investments in creating robust air, sea, and land infrastructure facilitated logistics and vaccine distribution, helping us keep supply chains resilient”.
Neither is the novel coronavirus a one-time affair. If predictions hold, COVID will be similar to seasonal colds or the flu: here to stay. When fall comes around each year, governments will need to vaccinate the world as quickly as possible to ensure long-term immunisation against the virus. This time, logistics companies must be better prepared.
Yet global immunisation, year after year, is no small order. To keep reinfection rates low and slow the spread of COVID, governments will likely need 7-9 billion annual doses of the vaccine to meet that mark. And if DHL’s white paper is any judge of success, multi-sector supply chain partnerships will set the gold standard.